Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.731 USD | +3.25% | +2.44% | -90.52% |
May. 21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
May. 08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.52% | 4.6M | |
+44.34% | 56.65B | |
-6.94% | 39.44B | |
+39.16% | 39.03B | |
-11.17% | 26.86B | |
+12.80% | 26.75B | |
-21.83% | 19.03B | |
+1.55% | 12.28B | |
+24.62% | 12.26B | |
+27.39% | 12.04B |
- Stock Market
- Equities
- CING Stock
- News Cingulate Inc.
- Top Premarket Gainers